Literature DB >> 1776464

Transferrin receptors and selective iron deposition in pancreatic B cells of iron-overloaded rats.

J P Lu1, K Hayashi, S Okada, M Awai.   

Abstract

Iron overload was produced in Wistar rats by repeated intraperitoneal injections of ferric nitrilotriacetate (Fe(3+)-NTA) for one to six months. Pancreatic tissues from these iron-overloaded rats and untreated controls were examined for insulin (for B cells), glucagon (for A cells), transferrin receptor (TfR), transferrin (Tf) and ferritin (Ft) using immunohistochemical methods, and for iron by histochemical Berlin blue staining. In the islets of iron-overloaded rats, increased Ft staining appeared prior to deposition of Berlin blue-stainable iron, and the staining intensity of Ft and iron was stronger in B cells than in A cells. In the islets of untreated control rats, the staining intensity of TfR was stronger in B cells than in A cells. TfR staining of the islets was weaker in iron-overloaded rats than in the controls. These findings suggest that 1) iron uptake by islet cells in vivo is regulated and mediated by TfR, 2) intracytoplasmic Ft transforms into stainable iron in iron-overloaded rats, and 3) predominance of TfR expression in B cells may result in selective deposition of iron and predispose B cells to damage and diabetes mellitus in iron-overloaded rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776464     DOI: 10.1111/j.1440-1827.1991.tb02787.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  2 in total

1.  The plasma membrane metal-ion transporter ZIP14 contributes to nontransferrin-bound iron uptake by human β-cells.

Authors:  Richard Coffey; Mitchell D Knutson
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-30       Impact factor: 4.249

2.  In silico identification and verification of ferroptosis-related genes in type 2 diabetic islets.

Authors:  Meiqi Yin; Liang Zhou; Yanan Ji; Rongxin Lu; Wei Ji; Guorong Jiang; Jin Ma; Xiudao Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.